Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 63.1
(1.25%)
CNY 63.1
(1.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.88 Billion CNY | 147.19% |
| 2022 | 759.28 Million CNY | 44.78% |
| 2021 | 524.44 Million CNY | 131277.38% |
| 2020 | 399.19 Thousand CNY | 11.11% |
| 2019 | 359.29 Thousand CNY | -77.74% |
| 2018 | 1.61 Million CNY | -39.38% |
| 2017 | 2.66 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 919.49 Million CNY | 18.2% |
| 2024 Q1 | 698.38 Million CNY | 11.72% |
| 2024 Q2 | 777.92 Million CNY | 11.39% |
| 2023 Q3 | 576.66 Million CNY | 27.75% |
| 2023 FY | 1.87 Billion CNY | 147.19% |
| 2023 Q4 | 625.09 Million CNY | 8.4% |
| 2023 Q2 | 451.38 Million CNY | 68.34% |
| 2023 Q1 | 268.14 Million CNY | 1.78% |
| 2022 Q3 | 207.98 Million CNY | 14.39% |
| 2022 Q2 | 181.81 Million CNY | 71.47% |
| 2022 Q1 | 106.03 Million CNY | 168.44% |
| 2022 FY | 759.28 Million CNY | 44.78% |
| 2022 Q4 | 263.45 Million CNY | 26.67% |
| 2021 Q2 | 83.32 Million CNY | 128.01% |
| 2021 Q4 | 39.49 Million CNY | -89.18% |
| 2021 FY | 524.44 Million CNY | 131277.38% |
| 2021 Q1 | 36.54 Million CNY | 33805.74% |
| 2021 Q3 | 365.07 Million CNY | 338.13% |
| 2020 Q3 | 45.61 Thousand CNY | 100.07% |
| 2020 FY | 399.19 Thousand CNY | 11.11% |
| 2020 Q2 | -65.47 Million CNY | -199.63% |
| 2020 Q1 | 65.71 Million CNY | 79984.33% |
| 2020 Q4 | 107.78 Thousand CNY | 136.32% |
| 2019 Q1 | 164.54 Million CNY | 0.0% |
| 2019 Q3 | 108.65 Thousand CNY | -24.6% |
| 2019 Q4 | 82.06 Thousand CNY | -24.47% |
| 2019 FY | 359.29 Thousand CNY | -77.74% |
| 2019 Q2 | 144.1 Thousand CNY | -99.91% |
| 2018 FY | 1.61 Million CNY | -39.38% |
| 2017 FY | 2.66 Million CNY | 0.0% |